Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families-Reference-Cited by-同舟云学术

Modulation of Osteoclast Differentiation and Function by the New Members of the Tumor Necrosis Factor Receptor and Ligand Families

Published:1999-06-01 Issue:3 Volume:20 Page:345-357
ISSN:0163-769X
Container-title:Endocrine Reviews
language:en
Short-container-title:

Author:

Suda Tatsuo¹,Takahashi Naoyuki¹,Udagawa Nobuyuki¹,Jimi Eijiro¹,Gillespie Matthew T.²,Martin T. John²

Affiliation:

1. Department of Biochemistry (T.S., N.T., N.U., E.J.), School of Dentistry, Showa University, Shinagawa-ku, Tokyo 142-8555, Japan;

2. St. Vincent’s Institute of Medical Research (M.T.G., T.J.M.), University of Melbourne, Fitzroy, Victoria 3065, Australia

Publisher

The Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/edrv/article-pdf/20/3/345/8864621/edrv0345.pdf

Reference83 articles.

1. Role of osteoblasts in hormonal control of bone resorption — a hypothesis.;Rodan;Calcif Tissue Int,1981

2. Regulation of osteoclast development and function In: Rifkin BR, Gay CV (eds) Biology and Physiology of the Osteoclast;Chambers;CRC Press, Boca Raton, FL, pp,1992

3. Advances in bone biology: the osteoclast.;Roodman;Endocr Rev,1996

4. Cellular biology of bone-resorbing cells.;Athanasou;J Bone Joint Surg Am,1996

5. Modulation of osteoclast differentiation.;Suda;Endocr Rev,1992

Cited by 1294 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RANK–RANKL–OPG Axis in MASLD: Current Evidence Linking Bone and Liver Diseases and Future Perspectives;International Journal of Molecular Sciences;2024-08-24

2. Physiopathologie (partie 1) – session « Rhumatologues en formation »;Revue du Rhumatisme;2024-08

3. Drug-induced osteoporosis and mechanisms of bone tissue regeneration through trace elements;Journal of Trace Elements in Medicine and Biology;2024-07

4. Repurposing the multiple sclerosis drug Siponimod for osteoporosis treatment;European Journal of Pharmacology;2024-07

5. Perinatal loss of galactosylceramidase in both oligodendrocytes and microglia is crucial for the pathogenesis of Krabbe disease in mice;Molecular Therapy;2024-07